Core Viewpoint - The article emphasizes that adopting an aggressive product strategy and focusing on specific high-growth sectors has become crucial for small and micro funds to maintain contract validity and achieve scale expansion [1]. Group 1: Shift to Aggressive Strategies - Small and micro funds are moving away from balanced approaches to focus on one or two high-growth sectors, enhancing net value elasticity and achieving performance breakthroughs [2][4]. - The recent quarterly reports show that several small funds have rapidly increased their scale from millions to billions, with some reaching 10 billion or even 100 billion, driven by aggressive product characteristics [1][2]. Group 2: Performance Examples - The Rongtong Mingrui Mixed Fund significantly increased its aggressive style by shifting its top ten holdings to focus entirely on the AI application industry, resulting in a return of over 37% within a month of 2026 [2]. - The Great Wall Consumer Value Fund also adjusted its holdings to focus on AI medical sector stocks, achieving a single-day net value increase of nearly 9% and a year-to-date return of 17.88% by January 25, 2026 [2]. - The Nuoan Selected Return Fund transitioned from a diversified approach to a concentrated military industry focus, achieving a return of nearly 26% at the start of the year [3]. Group 3: High Elasticity as a Key to Success - A distinct and high-elasticity sector style has become the core strategy for small and micro funds to achieve significant growth, with several funds experiencing explosive performance and scale growth in 2025 [5]. - The China Europe Digital Economy Fund, initially with a scale of less than 14 million yuan, saw its scale surge to over 11.7 billion yuan within two years, achieving a return of 143% in 2025 [5]. - The Chuangjin Hexin Global Pharmaceutical and Biotechnology Fund also saw its scale grow from 42 million yuan to 968 million yuan in just three months, driven by a return of 88.43% in 2025 [5]. Group 4: Correlation Between Fund Style and Scale - The strong correlation between fund style and scale is evident in the adjustments of certain products, where a shift to a more aggressive stock position led to a significant increase in scale from 11.88 million yuan to 198 million yuan [6]. - Conversely, when the fund's style was adjusted back to a conservative approach, its scale decreased significantly, highlighting the link between aggressive product styles and investor interest [6]. Group 5: Market Outlook and Strategy - Star fund managers are increasingly advocating for aggressive strategies, with a consensus emerging around focusing on sectors that benefit from improving risk appetite and capital market conditions [7]. - The manager of the E Fund Global Allocation Fund highlights the importance of focusing on AI-related industries and industrial resources, while also indicating a shift away from consumer and real estate sectors [7]. - Even more conservative fund managers are adjusting their portfolios to enhance elasticity, with a focus on technology and AI sectors expected to drive market recovery [8].

1月27日，外交部发言人郭嘉昆主持例行记者会。 彭博社记者提问，日本首相高市早苗表示，任何发生在台海的危机，都可能促使美日采取联合行动，以撤离各 自的公民。她还称，在这种情况下，日本不可能抛弃其长期盟友美国。中方对此有何评论？ 郭嘉昆表示，需要提醒日方的是，1972年《中日联合声明》明确，日本国政府承认中华人民共和国政府是中国 的唯一合法政府，中华人民共和国政府重申台湾是中华人民共和国领土不可分割的一部分，日本国政府充分理 解和尊重中国政府的这一立场，并坚持遵循《波茨坦公告》第八条的立场。1978年《中日和平友好条约》经中 日两国立法机构批准确认《中日联合声明》所表明的各项原则应予以严格遵守。 他指出，根据《开罗宣言》《波茨坦公告》和《日本投降书》等一系列具有充分国际法效力的文件，日本窃取 于中国之台湾必须归还中国，日本应完全解除武装，不得维持能使其重新武装的产业。日本宪法对军力交战 权、战争权也作出严格限制。以上这些都是日本必须严格履行的政治承诺和不容推卸的法律义务。日方声称要 在法律范围内行动，却一再粗暴干涉中国内政，甚至对中国发出武力威胁，这完全是自相矛盾。 违法和不良信息举报电话：0755-83514 ...

Core Viewpoint - The revised "Regulations for the Implementation of the Drug Administration Law of the People's Republic of China" aims to enhance drug innovation, streamline drug approval processes, and strengthen drug safety supervision, marking the first comprehensive revision in over 20 years [3][4]. Group 1: Drug Research and Registration - The new regulations support drug development and innovation guided by clinical value, encouraging the creation of new drugs and their clinical promotion [1][5]. - A fast-track registration process for new drugs has been established, along with clear re-registration procedures and mechanisms for converting prescription drugs to over-the-counter status [1][4]. - Special market exclusivity periods are granted for pediatric and rare disease medications, along with data protection for drugs containing novel chemical components [1][9]. Group 2: Drug Production Management - The regulations enforce strict management of drug contract manufacturing, clarifying the responsibilities of drug marketing authorization holders [2][13]. - Specific management requirements for the production and sale of traditional Chinese medicine (TCM) products have been outlined [2][12]. Group 3: Drug Distribution and Usage - The regulations improve the management of online drug sales, emphasizing the responsibilities of third-party platforms in drug transactions [2][10]. - Medical institutions are required to adhere to strict drug management practices to ensure the quality of drugs used [2][11]. Group 4: Drug Safety Supervision - The regulations specify measures for drug safety supervision and inspection, detailing the process for quality sampling and testing [2][5]. - Strict legal responsibilities for violations have been established to enhance accountability [2][5]. Group 5: Encouragement of Drug Innovation - The revised regulations explicitly encourage innovation by supporting clinical value-oriented drug research and improving the quality and efficacy of generic drugs [6][7]. - Four expedited approval pathways for breakthrough therapies, conditional approvals, and priority reviews have been formally included in the regulations [6][8]. Group 6: Intellectual Property Protection - The regulations strengthen the protection of drug intellectual property, introducing a market exclusivity period for innovative drugs [7][9]. - The exclusivity period for pediatric drugs is capped at two years, while rare disease drugs can receive up to seven years of exclusivity [9]. Group 7: Online Drug Sales Regulation - The regulations clarify the responsibilities and requirements for online drug sales platforms, mandating the establishment of dedicated management systems [11][10]. - The regulations also encourage the implementation of quality management standards for TCM production to enhance the quality of raw materials [11][12]. Group 8: Production Flexibility - The regulations allow for segmented contract manufacturing, enabling more efficient production of innovative drugs that require specialized processes [13][14]. - A pilot program for segmented production of innovative drugs will be initiated in select provinces starting in 2024 [14].

记者今天从国家疾控局了解到，本次印度暴发的尼帕病毒病疫情，主要发生在西孟加拉邦，与我国没有领土接 壤。尼帕病毒病主要通过直接接触感染的动物、病人及污染物传播，病毒环境存活力弱，一般民众接触感染机 会较少。综合研判，此次印度尼帕病毒病疫情对我国产生的影响相对较小。目前，我国尚未发现尼帕病毒病病 例。但也存在一定境外输入风险，需加强防范。 责编：汪云鹏 校对： 吕久彪 百万用户都在看 盘中，大幅拉升！20%涨停！芯片，突传重磅消息！ 直面争议！李蓓最新研判：黄金别再追了！地产拐点临近，价值投资将回归 突发！超2900架次航班，紧急取消！特大风暴，突袭美国 跨界并购！牛股尾盘，封死涨停！A股又一信号闪现 尾盘异动！A股，三大信号"闪现" 违法和不良信息举报电话：0755-83514034 邮箱：bwb@stcn.com 1998年，尼帕病毒病在国外首次发生并确认。此后，多个国家陆续报道发生尼帕病毒病疫情。我国疾控机构一 直密切关注境外尼帕病毒病疫情动态，持续做好监测防控相关工作。首先，2021年制定印发《尼帕病毒病预防 控制技术指南》，对疫情监测、报告、检测、诊断、调查处置、个人防护和消毒等疫情防控进行了规范。其 ...

Core Viewpoint - The article highlights the positive momentum in China's aircraft manufacturing sector, particularly focusing on the C919 narrow-body passenger aircraft, with an expected increase in production and delivery targets for 2024 and beyond [1][3]. Group 1: Market Reaction - A-share market saw a significant surge in the "big aircraft" concept stocks, with companies like Tuanan Co. and AVIC Aircraft Technology hitting over 10% gains, and the overall sector rising by more than 1.5% [1][3]. - The C919 aircraft has already seen two units roll off the production line within the first three weeks of the year, indicating a strong start for China Commercial Aircraft Corporation (COMAC) [1][3]. Group 2: Production and Delivery Insights - COMAC plans to deliver 28 or more C919 aircraft this year, a notable increase from previous targets, as supply chain issues are expected to improve significantly by the fourth quarter of 2025 [3][6]. - In 2025, COMAC is projected to deliver approximately 15 C919 aircraft, with a ramp-up in production observed in November and December of the previous year [3][6]. Group 3: International Certification and Market Expansion - The European Union Aviation Safety Agency (EASA) has begun flight evaluations of the C919 in Shanghai, indicating that the aircraft is performing well and is considered safe, which could facilitate its entry into European and other international markets [5][6]. - The article suggests that the C919 could expand its international market presence, with projections for deliveries to reach around 25 units in 2026, alongside an increase in domestic production capabilities [6][7]. Group 4: Future Outlook - The outlook for 2026 includes expectations for enhanced delivery rates and increased domestic production rates for the C919, as well as progress in the certification of the CJ-1000A engine [6][7]. - The article emphasizes the importance of improving the domestic supply chain and increasing the localization rate of key components in the aviation industry [6][7].

Core Viewpoint - The Hong Kong Securities and Futures Professionals Association highlights concerns over the high concentration of IPO sponsors in the market, which exacerbates the risk of declining application quality due to overburdened sponsors and a lack of experienced professionals [1][3]. Group 1: Market Concentration and Quality Concerns - The concentration of IPO sponsors is significant, with the top four sponsors handling 50% of the 216 IPO projects in 2025, indicating a market dominated by a few players [3]. - The association suggests that the current practice of sponsors handling multiple projects simultaneously may lead to a dilution of professional quality, resulting in poorly prepared listing documents [3][4]. - Recommendations include formalizing load management for sponsors and linking project load to compliance records to maintain professional standards [2][5]. Group 2: Talent Shortage and Its Impact - The industry faces a talent gap, with many experienced professionals lost during the pandemic and new hires lacking familiarity with Hong Kong's listing rules [6]. - This talent imbalance has led to a situation where seasoned professionals oversee projects while inexperienced staff handle execution, compromising the quality of work [6]. - The association calls for a systemic approach to rebuild the professional talent pipeline and encourages firms to establish sustainable training mechanisms [6]. Group 3: Regulatory Measures in Mainland China - In contrast, mainland China has implemented various measures to address the quality of IPO applications, including stricter oversight and evaluation of sponsor performance [7][8]. - The Chinese regulatory framework has set limits on the number of projects a sponsor can handle simultaneously, aiming to improve the quality of submissions [2][8]. - The concentration of IPO sponsorship in mainland China also mirrors that of Hong Kong, with the top five firms accounting for nearly half of the IPOs in 2025 [8].

来源：外交部网站 责编： 杨喻程 校对： 吕久彪 百万用户都在看 突发！超2900架次航班，紧急取消！特大风暴，突袭美国 刚刚，两部委突发利好！A股，迎来三大变数！ 100%关税！特朗普，突发威胁！ 跨界并购！牛股尾盘，封死涨停！A股又一信号闪现 尾盘异动！A股，三大信号"闪现" 违法和不良信息举报电话：0755-83514034 邮箱：bwb@stcn.com 看券商中国 知天下财经 弊中社 据外交部网站1月27日消息，外交部发言人宣布： 应国务院总理李强邀请，英国首相斯塔默将于1月28日至31日对中国进行正式访问。 券商中国 X 券中社 扫码下载 券 中 社 A P P 扫码关注券商中国公众号 quanshangcn qzs.stcn.com 券中社APP 券 商 中 国 是 证 券 市 场 权 威 媒 体 《 证 券 时 报 》 旗 下 新 媒 体, 券 商 中 国 对 该 平 台 所 刊 载 的 原 创 内 容 享 有 著 作 权 , 未 经 授 权 禁 止 转 载 ， 否 则 将 追 究 相 应 法 律 责 任 。 ...

Core Viewpoint - The article discusses the launch of the AI-powered trading app "AI Zhangle" by Huatai Securities, emphasizing its innovative features designed to enhance investment decision-making and reduce information asymmetry for retail investors [2][8]. Group 1: AI Zhangle Features - AI Zhangle integrates user-friendly functionalities into three core tools: "Early Listening" for market insights, "Special Reminder" for key market signals, and "Task Assistant" for executing trades efficiently [3][5]. - The app eliminates traditional multi-level menus, allowing users to focus on essential information and decision-making processes through a task-driven model [2][3]. - "Early Listening" provides personalized market interpretations and filters out irrelevant information, while "Special Reminder" alerts users to significant stock movements [3][4]. Group 2: Technology and Data Utilization - The app employs a complex "multi-agent" architecture, where a main agent coordinates various expert agents to provide tailored responses based on user queries [5][6]. - AI Zhangle utilizes a "Post-training" approach, leveraging historical data and proprietary knowledge to analyze market events and their implications for specific stocks [6][8]. - The app emphasizes the importance of high-quality data and clear logic in investment decisions, addressing user concerns about AI decision-making transparency [6][8]. Group 3: Market Position and Strategy - Huatai Securities aims to bridge the gap between retail and institutional investors by providing advanced financial services through AI Zhangle, making professional-grade tools accessible to a broader audience [8][9]. - The app is positioned as a distinct product focused on investment decision-making, differentiating itself from other AI investment tools in the market [9][10]. - The company is committed to ensuring security and compliance within the app, implementing multiple safeguards to protect user data and maintain trust [9].

Group 1 - The Ministry of Human Resources and Social Security will formulate the "Basic Rights Protection Measures for New Employment Form Workers" to clarify labor standards and corporate responsibilities for labor protection [1] - New policies will be introduced to protect the rights of elderly workers and to revise the "Paid Annual Leave Regulations" to ensure compliance by employers [1] - Measures will be implemented to address the impact of artificial intelligence on employment, including support initiatives for key industries and youth employment [1] Group 2 - The pilot program for occupational injury insurance will be expanded nationwide, with a target of 25.1 million insured participants by the end of 2025 [2] - By the end of 2025, the number of participants in basic pension, unemployment, and work injury insurance will reach 1.076 billion, 249 million, and 305 million respectively, showing increases of 3.16 million, 3.29 million, and 1.02 million compared to the previous year [2] - The total income of the three social insurance funds for the year is projected to be 9.1 trillion yuan, with total expenditures of 8.1 trillion yuan, resulting in a cumulative balance of 10.2 trillion yuan by the end of the year [2]

Core Viewpoint - The article discusses a legal case involving AI-generated misinformation, highlighting the concept of "AI hallucination" and its implications for liability and responsibility of AI service providers [1][4]. Group 1: Case Background - In June 2025, a high school student named Liang used an AI platform to inquire about college admission information, which resulted in the generation of inaccurate data regarding a university campus [2]. - Liang filed a lawsuit against the AI platform's developer, seeking compensation of 9,999 yuan due to the misleading information that he believed caused him to miss an admission opportunity [3]. Group 2: Court Ruling - The Hangzhou Internet Court ruled against Liang's lawsuit, stating that the AI's "promise" does not constitute a legal expression of intent from the platform, clarifying the boundaries of the service provider's duty of care [4]. - The court determined that AI does not possess civil subject status and cannot make legal declarations, thus the AI's generated compensation promise lacks legal effect [5]. Group 3: Liability Principles - The court applied the general fault liability principle from the Civil Code, rather than the strict liability principle applicable to product defects, due to the nature of AI services lacking specific quality standards [6]. - The court emphasized that the AI service provider's duty of care is dynamic and must adapt to the evolving nature of AI technology and its applications [7]. Group 4: Duty of Care - The court identified three layers of duty of care for AI service providers: 1. A strict obligation to review harmful or illegal content 2. A requirement to clearly inform users about the inherent limitations of AI-generated content 3. A basic duty to ensure functional reliability by employing industry-standard measures to enhance content accuracy [8]. - The court found that the defendant had adequately fulfilled its duty of care by providing clear warnings about the limitations of AI-generated content and implementing measures to improve reliability [8]. Group 5: Causation and Damages - The court ruled that Liang failed to provide sufficient evidence of actual damages resulting from the misleading information, thus could not establish a causal link between the AI's output and his alleged losses [7]. - The court concluded that the AI-generated misinformation did not significantly influence Liang's decision-making process regarding college applications, leading to the dismissal of the lawsuit [7].